Statistics for Cost-effectiveness analysis of a multicomponent meningococcal serogroup B vaccine in hypothetic epidemic situation in a middle-income country

Total visits

views
Cost-effectiveness analysis of a multicomponent meningococcal serogroup B vaccine in hypothetic epidemic situation in a middle-income country 0

Total visits per month

views
October 2024 0
November 2024 0
December 2024 0
January 2025 0
February 2025 0
March 2025 0
April 2025 0

File Visits

views
Cost-effectiveness analysis of a multicomponent meningococcal serogroup B vaccine in hypothetic epidemic situation in a middle-income country.pdf 9